HALISTER: Glaxo Looks at ViiV IPO to Capitalize on Surging HIV-Drug Sales

Glaxo Looks at ViiV IPO to Capitalize on Surging HIV-Drug Sales

Alert: HALISTER Source: BN (Bloomberg News)

Tickers GSK LN (GlaxoSmithKline PLC) 4507 JP (Shionogi & Co Ltd) PFE US (Pfizer Inc)

People Alistair Campbell (Joh Berenberg Gossler & Co KG) Andrew Witty (GlaxoSmithKline PLC)

Topics AIDS

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283